2023 年半年度报告 公司代码：600103 公司简称：青山纸业 福建省青山纸业股份有限公司 2023 年半年度报告 1 / 147 2023 年半年度报告 重要提示 五、 董事会决议通过的本报告期利润分配预案或公积金转增股本预案 无 六、 前瞻性陈述的风险声明 √适用 □不适用 本报告中所涉及的发展战略等前瞻性描述因存在不确定性，不构成公司对投资者的实质承诺 ，敬请投资者注意投资风险。 七、 是否存在被控股股东及其他关联方非经营性占用资金情况 否 八、 是否存在违反规定决策程序对外提供担保的情况？ 否 九、 是否存在半数以上董事无法保证公司所披露半年度报告的真实性、准确性和完整性 否 十、 重大风险提示 报告期内，不存在对公司生产经营产生实质性影响的特别重大风险。公司已在本报告中详细 阐述公司在未来生产经营过程中可能面临的各种风险及应对措施，包括政策风险、行业竞争风险、 环保监管趋严风险及原辅材料、能源价格风险等，敬请查阅第三节管理层讨论与分析中"可能面 对的风险"部分。 十一、 其他 □适用 √不适用 2 / 147 一、 本公司董事会、监事会及董事、监事、高级管理人员保证半年度报告内容的真实性、准确性 ...

证券代码：600103 证券简称：青山纸业 公告编号：临 2023-024 福建省青山纸业股份有限公司 关于参加福建辖区上市公司 2023 年投资者 网上集体接待日活动的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 为进一步加强与投资者的互动交流，福建省青山纸业股份有限公司（以下简 称"公司"）将参加由福建证监局、福建省上市公司协会与深圳市全景网络有限 公司联合举办的"2023 年福建辖区上市公司投资者网上集体接待日活动"，现 将相关事项公告如下： 本次活动将采用网络远程的方式举行，投资者可登录"全景路演"网站 （https://rs.p5w.net），或关注微信公众号：全景财经，或下载全景路演 APP, 参与本次互动交流，活动时间为 2023 年 5 月 15 日（周一）16:00-17:30。届时 公司高管将在线就公司 2022 年度业绩、公司治理、发展战略、 经营状况和可持 续发展等投资者关心的问题，与投资者进行沟通与交流，欢迎广大投资者踊跃参 与！ 特此公告！ 福建省青山纸业股份有限公司 2023 年 5 月 8 日 ...

Revenue and Profit Performance - Revenue for the first quarter of 2023 was RMB 703,345,414.21, a decrease of 9.90% year-over-year[4] - Net profit attributable to shareholders of the listed company was RMB 59,623,095.68, down 7.39% compared to the same period last year[4] - Total revenue for Q1 2023 was RMB 703.35 million, a decrease of 9.9% compared to RMB 780.66 million in Q1 2022[19] - Net profit for Q1 2023 was RMB 63.78 million, down 7.9% from RMB 69.28 million in Q1 2022[19] - Revenue for Q1 2023 was 479,959,781.59, a decrease from 538,487,020.31 in Q1 2022[26] - Net profit for Q1 2023 was 47,166,709.78, down from 58,700,287.90 in Q1 2022[26] - Operating profit for Q1 2023 was 61,423,482.85, compared to 76,657,990.63 in Q1 2022[26] Cash Flow and Operating Activities - Net cash flow from operating activities was negative RMB 83,178,455.92, a significant decrease of 174.62% year-over-year[4] - The decrease in operating cash flow was mainly due to a year-over-year reduction in sales proceeds received during the reporting period[7] - Net cash flow from operating activities in Q1 2023 was negative RMB 83.18 million, compared to positive RMB 111.46 million in Q1 2022[21] - Total cash inflow from operating activities in Q1 2023 was RMB 260.52 million, down 32.7% from RMB 387.17 million in Q1 2022[28] - Net cash flow from operating activities in Q1 2023 was negative RMB 116.93 million, compared to positive RMB 74.70 million in Q1 2022[28] Assets and Liabilities - Total assets at the end of the reporting period were RMB 5,866,520,967.17, an increase of 0.73% compared to the end of the previous year[4] - Equity attributable to shareholders of the listed company was RMB 3,924,021,339.45, up 1.54% from the end of the previous year[4] - The company's total assets as of March 31, 2023, amounted to RMB 5,866,520,967.17, with current assets totaling RMB 3,676,278,097.64 and non-current assets at RMB 2,190,242,869.53[16] - Total liabilities as of Q1 2023 were RMB 1.64 billion, a slight decrease from RMB 1.66 billion in the previous quarter[17] - Total equity as of Q1 2023 was RMB 4.23 billion, an increase from RMB 4.16 billion in the previous quarter[17] - Total assets at the end of Q1 2023 were RMB 4.861 billion, a slight decrease of 0.1% from RMB 4.866 billion at the end of 2022[23] - Total liabilities decreased to 1,372,013,286.01 from 1,424,607,461.72 compared to the previous period[24] - Total owner's equity increased to 3,488,559,500.39 from 3,441,392,790.61[24] Earnings and Shareholder Equity - Basic earnings per share were RMB 0.0270, a decrease of 7.39% year-over-year[4] - Weighted average return on equity was 1.53%, a decrease of 0.22 percentage points[4] - Basic earnings per share for Q1 2023 were RMB 0.027, down from RMB 0.029 in Q1 2022[19] - The company's 2022 annual profit distribution plan proposes a cash dividend of RMB 0.50 per share, totaling RMB 110,616,452.35, representing 53.25% of the net profit attributable to the parent company[12] Investments and Financial Activities - Non-recurring gains and losses amounted to RMB 11,240,932.90, primarily due to gains from financial asset investments[6] - The company's subsidiary, Xian Shui Pharmaceutical, is authorized to use idle funds of up to RMB 200 million for cash management, with a maximum investment period of 12 months[13] - The company's subsidiary, Shenzhen Hengbaotong, is authorized to use idle funds of up to RMB 50 million for cash management, with a maximum investment period of 12 months[14] - Cash received from investment returns in Q1 2023 was RMB 1.006 billion, a decrease of 36.0% compared to RMB 1.573 billion in Q1 2022[21] - Cash used for investments in Q1 2023 was RMB 980 million, a decrease of 37.4% compared to RMB 1.566 billion in Q1 2022[21] - Net cash flow from financing activities in Q1 2023 was RMB 4.95 million, a significant decrease from RMB 177.67 million in Q1 2022[21] - Cash received from investment returns in Q1 2023 was RMB 1.01 billion, a decrease of 36.0% from RMB 1.57 billion in Q1 2022[28] - Cash outflow for investments in Q1 2023 was RMB 980.00 million, down 36.4% from RMB 1.54 billion in Q1 2022[28] - Net cash flow from investing activities in Q1 2023 was RMB 18.83 million, a decrease of 31.1% from RMB 27.31 million in Q1 2022[28] - Cash received from borrowings in Q1 2023 was RMB 100.00 million, down 61.5% from RMB 260.00 million in Q1 2022[28] - Net cash flow from financing activities in Q1 2023 was RMB 6.37 million, a significant decrease of 96.2% from RMB 169.16 million in Q1 2022[28] Subsidiaries and Legal Matters - The company's subsidiary, Guangzhou Qingzhi Packaging Materials Co., Ltd., won a lawsuit with a claim amount of RMB 9,114,900 and is expected to receive RMB 10,014,590.54 from the execution of the judgment[11] Shareholder Information - The top shareholder, Fujian Energy Group Co., Ltd., held 220,338,982 shares, representing 9.56% of the total shares[8] - The company's share repurchase account holds 93,488,760 shares, representing 4.05% of the total shares as of the end of the reporting period[9] R&D and Operating Costs - R&D expenses increased by 56.1% to RMB 12.46 million in Q1 2023 compared to RMB 7.98 million in Q1 2022[19] - Total operating costs for Q1 2023 were RMB 632.24 million, a decrease of 10.1% compared to RMB 703.30 million in Q1 2022[19] Financial Metrics and Ratios - The company's cash and cash equivalents decreased from RMB 1,113,341,964.15 at the end of 2022 to RMB 1,049,877,212.51 as of March 31, 2023[16] - The company's trade receivables increased significantly from RMB 103,119,930.90 at the end of 2022 to RMB 326,204,037.87 as of March 31, 2023[16] - The company's inventory decreased from RMB 599,133,393.97 at the end of 2022 to RMB 535,033,449.11 as of March 31, 2023[16] - The company's short-term borrowings decreased from RMB 432,107,898.32 at the end of 2022 to RMB 412,052,715.82 as of March 31, 2023[16] - Long-term borrowings increased by 21.0% to RMB 171.36 million in Q1 2023 from RMB 141.56 million in the previous quarter[17] - Accounts payable increased by 22.2% to RMB 339.76 million in Q1 2023 from RMB 278.04 million in the previous quarter[17] - Contract liabilities decreased by 55.4% to RMB 21.84 million in Q1 2023 from RMB 48.91 million in the previous quarter[17] - Sales revenue from goods and services in Q1 2023 was RMB 433.91 million, a decrease of 29.6% compared to RMB 616.21 million in Q1 2022[21] - Monetary funds at the end of Q1 2023 were RMB 694.99 million, a decrease of 11.7% from RMB 786.82 million at the end of 2022[23] - Trade receivables at the end of Q1 2023 were RMB 114.13 million, a significant increase from RMB 3.73 million at the end of 2022[23] - Financial expenses decreased to 1,067,618.24 from 3,451,823.66 year-over-year[26] - Interest income increased to 2,626,094.84 from 1,060,076.35[26] - Other income rose to 1,400,484.77 from 321,910.40[26] - Investment income dropped to 6,619,339.62 from 13,492,960.70[26] - Credit impairment losses increased to -2,489,897.88 from -1,144,790.05[26] - Sales revenue from goods and services in Q1 2023 was RMB 254.76 million, a decrease of 33.2% compared to RMB 381.46 million in Q1 2022[28] - Net increase in cash and cash equivalents in Q1 2023 was negative RMB 91.84 million, compared to positive RMB 271.16 million in Q1 2022[28] - Ending cash and cash equivalents balance as of March 31, 2023 was RMB 689.90 million, an increase of 45.9% from RMB 472.98 million as of March 31, 2022[28]

Financial Performance - Revenue for 2022 reached 2.92 billion RMB, a 1.87% increase compared to 2021[22] - Net profit attributable to shareholders in 2022 was 207.74 million RMB, up 9.17% year-over-year[22] - Cash flow from operating activities in 2022 was 386.27 million RMB, a 16.28% decrease from 2021[22] - Total assets at the end of 2022 were 5.82 billion RMB, an 8.03% increase compared to 2021[22] - The company's total equity attributable to shareholders at the end of 2022 was 3.86 billion RMB, a 5.70% increase from 2021[22] - The company's diluted earnings per share for 2022 were 0.09 RMB, up 9.17% from 2021[22] - The company's net profit margin for 2022 was 7.11%, up from 6.64% in 2021[22] - The company's return on equity (ROE) for 2022 was 5.38%, up from 5.21% in 2021[22] - The company's debt-to-asset ratio at the end of 2022 was 33.63%, down from 34.12% in 2021[22] - Total revenue for 2022 was 2,285,406,085.34 yuan, a slight increase of 0.63% compared to the previous year[65] - The company's financial expenses decreased sharply by 91.09% to 2,215,099.61 yuan due to reduced interest payments and increased exchange gains[67] R&D and Innovation - R&D expenses increased significantly by 52.24% to 75,645,432.85 yuan, driven by increased investment in product development projects[67] - The company has 341 R&D personnel, accounting for 10.35% of the total workforce, with 151 holding bachelor's degrees[69] - Total R&D investment reached 75,945,432.85 yuan, representing 2.60% of total revenue, with only 0.40% being capitalized[68] - The company obtained 4 new patents, including 1 invention patent and 3 utility model patents[70] - The company has become the first in China to master the production technology of bamboo dissolving pulp and large-scale clean bamboo pulp papermaking, with the quality of refined bamboo pulp exceeding expectations[97] - The company aims to promote the development of the photoelectric industry, focusing on high-speed optical module R&D and application, and plans to achieve breakthroughs in high-end customer markets and large-scale production delivery[101] - The company will implement a talent-driven strategy, increase R&D investment, and promote intelligent transformation to achieve cost reduction, quality improvement, and efficiency enhancement[101] Business Strategy and Expansion - The company plans to distribute a cash dividend of 0.50 RMB per 10 shares, totaling 110.62 million RMB, representing 53.25% of the net profit attributable to shareholders[5] - The pharmaceutical industry is a key profit source for the company, with stable income and performance over the years, but the development pace is slow and the scale is small, necessitating accelerated growth[97] - The company plans to expand its pharmaceutical business through its subsidiary, Shui Xian Pharmaceutical, by entering new chemical drug fields, upgrading technology, increasing R&D, and deepening marketing reforms[97] - The company is committed to the "green papermaking, meticulous pharmaceutical" dual-drive strategy, focusing on digital, intelligent, green, and high-end development in the pulp and paper industry[100] - The company plans to develop green bamboo fiber products, such as bleached bamboo pulp, environmentally friendly kraft paper, and stretchable paper, to lead industry agglomeration and occupy a place in the "paper instead of plastic" trend[100] - The company aims to achieve carbon peak and carbon neutrality goals by improving energy efficiency, reducing emissions, and enhancing environmental governance[100] - The company plans to extend its industrial chain, consolidate raw material supply systems, and strengthen its market dominance[102] - The company will promote the construction of a green circular economy industrial park, focusing on the application of natural bamboo fibers and the development of new textile materials[103] Sales and Procurement - Sales to the top five customers amounted to 615.28 million yuan, representing 21.06% of total annual sales[66] - Procurement from the top five suppliers was 871.15 million yuan, accounting for 38.21% of total annual procurement[66] Cost Management - The medical sector saw a 5.20% increase in raw material costs, reaching 998.74 million yuan[64] - The wood sector experienced a significant 66.20% increase in forest cultivation costs, totaling 2.27 million yuan[64] Corporate Governance - The company's total number of employees is 3,294, with 1,802 in the parent company and 1,492 in major subsidiaries[147] - The company's workforce consists of 2,037 production personnel, 174 sales personnel, 602 technical personnel, 100 financial personnel, and 381 administrative personnel[148] - The educational background of employees includes 11 with postgraduate degrees, 466 with bachelor's degrees, 633 with associate degrees, 1,053 with vocational diplomas, and 1,131 with high school education or below[148] - The company's Board of Directors held 7 meetings in 2022, with 5 conducted via teleconference and 2 via a combination of in-person and teleconference[143] - Independent director He Juan raised an objection to the proposal of changing the use of remaining raised funds for working capital, citing concerns about the superiority of the new project compared to the original one[144] - The company's Audit Committee held 6 meetings in 2022, focusing on annual reports, financial audits, and internal control evaluations[146] - The company approved a proposal to transfer idle real estate assets of a wholly-owned subsidiary during the 9th 19th Board Meeting on April 1, 2022[141] - The company approved the construction of a bag production line project by a wholly-owned subsidiary during the 9th 18th Board Meeting on March 25, 2022[141] - The company approved the implementation of a production control center and substation technical renovation project during the 9th 21st Board Meeting on August 19, 2022[141] - The company approved the construction of an alkali recovery technical renovation project during the 9th 22nd Board Meeting on September 30, 2022[141] Environmental and Social Responsibility - The company's internal control system is well-structured and meets the requirements of the Ministry of Finance, China Securities Regulatory Commission, and other relevant authorities, ensuring effective management and development[159] - The company invested 4.5 million yuan in environmental protection during the reporting period[164] - The company achieved a domestic clean production level of Grade III and has been rated as an "Environmental Integrity Enterprise" or "Environmental Good Enterprise" by the Fujian Provincial Department of Ecology and Environment for 8 consecutive years[166] - The company has 2 wastewater discharge outlets and 6 exhaust gas discharge outlets, all of which comply with national emission standards[166][167] - In 2022, the company's wastewater discharge totaled over 10.98 million tons, with a treatment cost of 38.14 million yuan[169] - The company's COD (Chemical Oxygen Demand) emission concentration was 63.74 mg/L, well below the standard limit of 90 mg/L[168] - The company's NH3-N (Ammonia Nitrogen) emission concentration was 2.11 mg/L, significantly lower than the standard limit of 8 mg/L[168] - The company's SO2 (Sulfur Dioxide) emission concentration was 14.10 mg/m³, far below the standard limit of 200 mg/m³[168] - The company's NOX (Nitrogen Oxides) emission concentration was 22.9 mg/m³, well under the standard limit of 200 mg/m³[168]

2022 年第三季度报告 证券代码：600103 证券简称：青山纸业 福建省青山纸业股份有限公司 2022 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大 遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完 整，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中 财务信息的真实、准确、完整。 第三季度财务报表是否经审计 □是 √否 一、主要财务数据 主要会计数据和财务指标 单位：元 币种：人民币 项目 本报告期 本报告期 比上年同 期增减变 动幅度(%) 年初至报告期末 年初至报告期 末比上年同期 增减变动幅度 (%) 营业收入 702,333,644.10 1.21 2,287,382,836.10 8.06 归属于上市公司股东的 净利润 46,501,596.74 10.77 176,007,525.05 14.34 归属于上市公司股东的 扣除非经常性损益的净 利润 35, ...

2022 年半年度报告 公司代码：600103 公司简称：青山纸业 福建省青山纸业股份有限公司 2022 年半年度报告 1 / 132 四、公司负责人张小强、主管会计工作负责人林小河及会计机构负责人（会计主管人员）余 建明声明：保证半年度报告中财务报告的真实、准确、完整。 2022 年半年度报告 五、董事会决议通过的本报告期利润分配预案或公积金转增股本预案 重要提示 报告期内，公司无利润分配预案或公积金转增股本预案。 一、本公司董事会、监事会及董事、监事、高级管理人员保证半年度报告内容的真实性、准 确性、完整性，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 二、公司全体董事出席董事会会议。 三、本半年度报告未经审计。 十一、其他 □适用 √不适用 八、是否存在违反规定决策程序对外提供担保的情况？ 否 九、是否存在半数以上董事无法保证公司所披露半年度报告的真实性、准确性和完整性 否 十、重大风险提示 报告期内，不存在对公司生产经营产生实质性影响的特别重大风险。公司已在本报告中详细 阐述公司在未来生产经营过程中可能面临的各种风险及应对措施，包括政策风险、行业竞争风险 及原辅材料、能源价格风险 ...

2022 年第一季度报告 证券代码：600103 证券简称：青山纸业 福建省青山纸业股份有限公司 2022 年第一季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大 遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整， 不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务 报表信息的真实、准确、完整。 第一季度财务报表是否经审计 □是 √否 一、 主要财务数据 (一)主要会计数据和财务指标 单位：元 币种：人民币 | 项目 | | 本报告期 | 本报告期比上年同期增减 | | | --- | --- | --- | --- | --- | | | | | 变动幅度(%) | | | 营业收入 | | 780,655,972.48 | | 12.83 | | 归属于上市公司股东的净利润 | | 64,379,735.18 | | 6.21 | | 归属于上市公司股东的扣除非经常性 ...

2021 年年度报告 公司代码：600103 公司简称：青山纸业 福建省青山纸业股份有限公司 2021 年年度报告 1 / 179 2021 年年度报告 重要提示 一、本公司董事会、监事会及董事、监事、高级管理人员保证年度报告内容的真实性、准确 性、完整性，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 二、公司全体董事出席董事会会议。 三、华兴会计师事务所(特殊普通合伙)为本公司出具了标准无保留意见的审计报告。 四、公司负责人张小强、主管会计工作负责人林小河及会计机构负责人(会计主管人员)余建 明声明：保证年度报告中财务报告的真实、准确、完整。 五、董事会决议通过的本报告期利润分配预案或公积金转增股本预案 经华兴会计师事务所(特殊普通合伙)审计，公司2021年度母公司实现净利润148,684,221.33 元，公司母公司年初未分配利润-28,556,217.16元，年末可供全体股东分配的未分配利润 108,115,203.75元，年末资本公积余额811,107,281.82元。根据《上海证券交易所上市公司自律 监管指引第1号----规范运作》、《公司章程》及《公司未来三年(2021-20 ...

2021 年第三季度报告 证券代码：600103 证券简称：青山纸业 福建省青山纸业股份有限公司 2021 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏， 并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完 整，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中 财务报表信息的真实、准确、完整。 第三季度财务报表是否经审计 □是 √否 一、 主要财务数据 2021 年第三季度报告 (二)非经常性损益项目和金额 | | | | 单位：元 币种：人民币 | | --- | --- | --- | --- | | 项目 | 本报告期金额 | 年初至报告期末 金额 | 说明 | | 非流动性资产处置损益（包括已计提资产减值 | -61,329.35 | -62,489.25 | | | 准备的冲销部分） | | | | | 越权审批，或无正式批准文件，或偶发性的税 | | | | ...

2021 年半年度报告 公司代码：600103 公司简称：青山纸业 福建省青山纸业股份有限公司 2021 年半年度报告 1 / 144 2021 年半年度报告 重要提示 一、本公司董事会、监事会及董事、监事、高级管理人员保证半年度报告内容的真实、准确、 完整，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 二、公司全体董事出席董事会会议。 三、本半年度报告未经审计。 四、公司负责人张小强、主管会计工作负责人林小河及会计机构负责人（会计主管人员）余 建明声明：保证半年度报告中财务报告的真实、准确、完整。 五、董事会决议通过的本报告期利润分配预案或公积金转增股本预案 报告期内，公司无利润分配预案或公积金转增股本预案。 六、前瞻性陈述的风险声明 □适用 √不适用 七、是否存在被控股股东及其关联方非经营性占用资金情况 否 八、是否存在违反规定决策程序对外提供担保的情况？ 否 九、是否存在半数以上董事无法保证公司所披露半年度报告的真实性、准确性和完整性 否 十、重大风险提示 报告期内，不存在对公司生产经营产生实质性影响的特别重大风险。公司已在本报告中详细 阐述公司在未来生产经营过程中可能面临的各种风 ...